content_copy Pipeline - Vitro Biopharma

Robust Pipeline

The company’s innovative and proprietary technology platform leverage Wharton's jelly of the umbilical cord-derived cell therapy products, translating ground-breaking science into medicines that transform the lives of our patients. The current pipeline can be used to treat chronic diseases in immunology and other therapeutic areas. Vitro is advancing multiple clinical trials across its product portfolio.